chrisvoncsefalvay/vaers-outcomes huggingface dataset:
?Pfizer-BioNTech COVID-19 Vaccine EUA" 5 minutes after administration of Pfizer COVID vaccine, patient passed out for less than a minute. Patient was alert, knew where he was and what had just happen. He stated he was not experiencing chest pain, shortness of breath, no rash observed. Patient stated he tends to pass out at the site of needles or when he was blood drawn.  10 minutes after passing patient begin to feel lightheaded, skin tone become very pale and patient stated he was hot. Patient passed out a 2nd time and experience 2 body jerk movements  for less than a minute. Epi Pen was administered to the patient. Paramedics were called to the scene. Patient become alert and patient stated he need to vomit. Patient vomited profusely. Vitals were taken: BP 100/60mmhg, O2 stat 97%, Temperature 96.5F. Paramedics arrived at scene. Paramedics spoke with patient let him know his vitals were stable and if he would like to be taken down to the ER. Patient declined stated he was feeling much better. On 3.10 patient was contacted and he stated he was feeling great, just experiencing soreness at the site on Pfizer vaccine and Epi pen administration site.
11/1 Received shot - had chills evening and during night. Headache following day. Felt fine by Friday 11/3.
Memory loss; Brain fog; chest pains; breast inflammation and infection; breast inflammation and infection; fatigue; Prev dose administration date=10Aug2020, prev dose dose number=1 / administration date=02Nov2020, dose number=2; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Nov2020 as dose 2, single (Batch/Lot number: unknown) at the age of 39 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left), administration date: 10Aug2020, when the patient was 39-year-old, for COVID-19 Immunization.  The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 02Nov2020, outcome "unknown", described as "Prev dose administration date=10Aug2020, prev dose dose number=1 / administration date=02Nov2020, dose number=2"; BRAIN FOG (hospitalization, disability) with onset 02Dec2021, outcome "not recovered"; AMNESIA (hospitalization, disability) with onset 02Dec2021, outcome "not recovered", described as "Memory loss"; MASTITIS (hospitalization, disability), BREAST INFLAMMATION (hospitalization, disability) all with onset 02Dec2021, outcome "not recovered" and all described as "breast inflammation and infection"; CHEST PAIN (hospitalization, disability) with onset 02Dec2021, outcome "not recovered", described as "chest pains"; FATIGUE (hospitalization, disability) with onset 02Dec2021, outcome "not recovered". The patient was hospitalized for amnesia, brain fog, chest pain, mastitis, breast inflammation, fatigue (hospitalization duration: 3 day(s)). The events "memory loss", "brain fog", "chest pains", "breast inflammation and infection" and "fatigue" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Feb2022) Negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of amnesia, brain fog, chest pain, mastitis, breast inflammation, fatigue.  Clinical course: No Covid prior vaccination. Covid tested post vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient had eyes roll back, slumped to the right side on exam table, some posturing of feet. Episode lasted 30-45 seconds and received occurred 4 minutes after vaccine was given. Bradycardia to 49 after event and hypotensive x15-20 minutes.
Information has been received from a physician concerning a female patient who in September 2008 and November 2009 was vaccinated with the first and second dose of GARDASIL. On 02-APR-2009 the patient was vaccinated with the third dose of GARDASIL IM 0.5ml. "A week and a half ago" on approximately 07-JUN-2009 the patient developed "a rash on her arms and legs". "The patient's other doctor" said that it was due to GARDASIL. Unspecified medical attention had been sought. No further information is available.
Patient developed numbness in her lips, had some tachycardia, and dizziness around 5:30 pm. Patient then notified one of the physician who advised her to monitor symptoms and notify on call provider if symptoms worsened. Patient then went home and slept and the next morning was feeling better.
Initial report was received from a health care professional on 18 Dec 2009: This patient (18 month old) was inadvertently given FLUVIRIN 0.5 ml, intramuscular on an unknown date. No adverse events were reported.
my body developed an elevated inflamation event in my neck, shoulders and hands.  It has since been diagnosed as Polymyalgia Rhuematica.; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient (not pregnant) received bnt162b2 (BNT162B2 also reported as Pfizer COVID-19 vaccine, lot unknown), via an unspecified route of administration in the left arm on 26Mar2021 10:00 as second dose, single for Covid-19 immunisation. Medical history included osteoarthritis, allergic to penicillin and shrimp. She had her first dose of bnt162b2 on 05Mar2021 (lot unknown) at 10:00am in the left arm. The patient's concomitant medications were not reported. On 14Apr2021 (also reported as within a week of last dose), the patient informed her body developed an elevated inflammation event in her neck, shoulders and hands and diagnosed as Polymyalgia Rhuematica in which she had a clinic visit to a doctor or other healthcare professional office. This was treated with prednisone. The outcome of event was recovering.  Information on the lot/batch number has been requested.
On October 12th, red raised lesion appeared on lower right arm/wrist area.  Another smaller red raised lesion appeared on the pinky finger of the left hand.  Both lesions painful.
Information has been received from a pharmacist referring to a patient of unknown age and gender. On 17-FEB-2016 the patient was vaccinated with an expired dose of ZOSTAVAX (lot # K20185, expiration date 27-JAN-2016) (dose and route were not reported). No adverse effect was reported. Additional information has been requested.
Fever, chills, myalgias, arthralgias, fatigue, dizziness, headache, nausea, injection site pain -started about 8 hrs after vaccination and lasted for about 2 days.  About 40 hours after vaccination developed decreased sensation, numbness over left side of the scalp and in next few hours had numbness of left side of face, arm and fingers with some weakness in grip and fine motor movements. Has been the same since then.  Fe hours later started having
PATIENT HAD BEEN IN TO DR. AND HIS MD SAW HIS ARM, TOLD HIM TO TELL US ABOUT IT..  ARM WAS RED, ITCHING AND SWOLLEN.  TOLD PATIENT TO TAKE AN ANTIHISTAMINE AND USE HYDROCORTISONE PLUS ICE PACKS TO REDUCE SWELLING AND INFLAMMATION.  PATIENT SAYS IT DOES NOT HURT HIM.
Got the first dose of the new vaccine / I couldn't afford it I didn't get the 2 dose; This case was reported by a consumer via media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (lasted for a solid year, ten years or more ago). Previously administered products included Shingles vaccine (received 1st dose on an unknown date) and Shingles vaccine (received a vaccine, a few years ago). Concurrent medical conditions included systemic lupus erythematosus.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix as per the vaccination schedule, which led to incomplete course of vaccination. The patient got a vaccine a few years ago, and a year later the patient's doctor said that vaccine was not a good vaccine and the patiet had to get the new vaccine that required 2 doses. The patient stated that, when he or she went to take the second dose they wanted to charge the patient for it because they said the patient had reached the donut hole of his or her insurance deductible and since couldn't afford it. The patient was a retired senior, so he or she had the dose that they said was no longer good.
Information has been received from a certified medical assistant concerning a 72 year old female patient with hypertension, chronic obstructive pulmonary disease and gastrooesophageal reflux disease and a history of cerebrovascular accident and diverticulitis who on 23-OCT-2007, was vaccinated IM into the right arm with a first 0.5ml dose of PNEUMOVAX 23 (Lot# 658555/0964U).  Concomitant therapy included influenza virus vaccine (unspecified) administered into the left arm, KLOR-CON, COZAAR, ZOCOR, CARTIA XT, metoprolol, AGGRENOX, ADVAIR, PRILOSEC and LASIX.  Subsequently, the patient experienced arm pain, redness at the injection site, warmth at the injection site and swelling in the right arm.  Unspecified medical attention was sought.  Laboratory diagnostic studies included an ultrasound of the arm which was reported as negative for deep vein thrombosis (DVT).  At the time of this report, the patient's outcome was unknown.  No product quality complaint was involved.  This is one of 4 reports from the same source.  Additional information has been requested.
Patient called on 4/2/21 stating 1 hour she received the Covid vaccine, her tongue began to swell. Pt immediately took Benadryl and tongue swelling went away. Patient denies any other symptoms now. RN notified primary care provider, Dr. of event and provider verbalized understanding.
No adverse reaction occured. A 10 mcg dose diluted to 0.3 ml was administered. The patient was underage for the vaccine that was administered.
Cyanosis to fingers and hands bilaterally with blueness noted lasting an hour on two separate occasions - 4/5/2021 and 4/8/2021. Patient monitored with no signs of central cyanosis or other problems. Discharged home to follow-up with PCP.  Patient also reported chest pain and dyspnea on 3/28/2021, 3 days after vaccine with no emergent findings.
1/17/2020 Telephone call to clinic. . C/o of having a rough night unable to sleep.  due to pain to (L arm)  at site of pneumonia, c/o of chill and  high fever..  1/21/2020 called client doing better, still complaining of arm soreness, and low grade temperature.
fever on and off; I''ve been having a low grade and a high grade fever; it''s been more than 24 hours that I''ve had fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Lot number: FL3197) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization. The following information was reported: PYREXIA (non-serious), outcome "not recovered", described as "fever on and off; I''ve been having a low grade and a high grade fever; it''s been more than 24 hours that I''ve had fever". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was stated, Basically patient was just concerned about that have been having a fever on and off since patient got 2nd dose of Pfizer. Patient got it on Thursday and then started feeling fever around 10 O' Clock that night and patient have been having a low grade and a high grade fever like ever since then. It was stated, Yeah, patient just wanted to know was it normal that it was been going on for now like more patient would say more than a day because it was been more than 24 hours that have had fever.  No follow-up attempts are possible. No further information is expected.
The pt states that 2 days, post vax, she developed severe headache, lightheadedness, blurred vision and increased fatigue. She also complained of respiratory symptoms of congestion.
Gardasil vaccine - Nausea, diarrhea, cramping, severe case of hives lasting several days, malaise. Patient is frequently getting hives to this day. Patient had never had hives prior to vaccination reaction.
Information has been received from a physician concerning a patient who was vaccinated with a 1 ml dose of Pneumovax 23 (lot #655587/0882F). Subsequently the patient experienced are swelling from shoulder to wrist. Unspecified medical attention was sought, this patient may have sought medical attention in the emergency room. This is one of 3 reports from the same source. Additional information has been requested.
No additional adverse event; the patient was inadvertently administered a dose of ROTATEQ that was expired; This spontaneous report was received from a registered nurse and refers to a 10-week-old male patient. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On 22-JUL-2020, the patient was inadvertently vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # R033252, expiration date 29-JUN-2020, (exact dose, injection site and route of administration were not reported) for prophylaxis. No additional adverse event was reported.
Brain fog, less energy (first 72 hrs) Worst diarrhea in my life, cleared out my gut. I could tell what I ate because it was floating in the water undigested (sometimes) Lasted until Tuesday, and just pooped again Thursday and Friday.
Information has been received from a nurse practitioner concerning a 4 year old male with no pertinent medical history and no drug allergy who on 06-JUN-2011 was vaccinated with the first dose of PROQUAD (Merck) (dose and route not reported, lot# 664339/0182Z). Concomitant therapy included DTaP-Polio. On 07-JUN-2011 the patient experienced injection site reaction after his first vaccination with PROQUAD (Merck). The site was swollen and red. The reaction was 3.75cm x 2.25cm in size. No rash. The patient was seen in the office on 09-JUN-2011 and was given BENADRYL and cool compresses. No lab diagnostics study was performed. At the time of reporting, the patient was recovering. Follow up information has been received from the nurse practitioner concerning a 4 year old male with gluten hypersensitivity who on 08-JUN-2011 experienced erythema with edema to injection site. On 09-JUN-2011, reaction site measured 3.75cm x 2.25cm on right thigh. The patient required doctor visit. On an unknown date, the patient recovered. Additional information is not expected.
Two days after receiving the flu shot I developed severe pain in my throat, difficulty in swallowing, a sharp pain accompanies each time I swallow, soreness, terrible scratchy feeling each time I swallow along with pain. A stiff neck, no temperature. Fatigue, loss of appetite. This is the 7th day since I received the shot.
This is a spontaneous report from a contactable consumer reporting for herself. A 70-year-old female patient received PREVNAR 13, via an unspecified route of administration, on an unspecified date around a year before report, at single dose, for immunisation. Medical history included ongoing diabetes mellitus, ongoing blood pressure abnormal, ongoing heart rate abnormal, food allergy (to eggs), latex allergy. Concomitant medication included CARDIZEM from an unspecified date and ongoing since 10 years for blood pressure and heart rate, metformin (unspecified trade name) from an unspecified date and ongoing since 15 years or longer for diabetes, glipizide (unspecified trade name) from many years for diabetes, labetalol (unspecified trade name) for blood pressure. The patient experienced fever for 3 days and severe headache for 3 days both the day after vaccination with outcome of recovered. On an unspecified date a year after the patient received PREVNAR 13 again and experienced severe headache for 3 or more days and fever for 3 or more days both with outcome of recovered. The information on the lot number has been requested.
2 wks after MMR, developed lethargy and edema. Hospitalized 10/30-11/3 with acute glomerulone periods. Kidney bx done= no sclerosis. Dx'ed by MD at hospital with autoimmune response to MMR, hospitalized again 11/15-11/19 for IV Prednisone high dose, continues on Prednisone and QOD lab tests for BUN and Creatinine.
Five hours following immunization, pt developed high fever. He was taken to ER and was admitted for meningitis.
Headache, NauseaVomiting, weakness Narrative:  Following the vaccine, the patient reported experiencing weakness, nausea, and a headache. She took acetaminophen 650mg every 4 hours to manage her symptoms.  Other Relevant History:
Elevated monocytes; This non-serious case was reported by a consumer via call center representative and described the occurrence of monocyte count increased in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26-JUN-2023, the patient received the 2nd dose of Shingrix. On 29-JUN-2023, 3 days after receiving Shingrix, the patient experienced monocyte count increased (Verbatim: Elevated monocytes). The outcome of the monocyte count increased was unknown.   It was unknown if the reporter considered the monocyte count increased to be related to Shingrix.     It was unknown if the company considered the monocyte count increased to be related to Shingrix.   Additional Information: GSK Receipt date: 30-JUN-2023 A reporter reported about him self she received her second dose of SHINGRIX on Monday 26 June 2023 and the patient had routine blood work, in preparation for a physical on Thursday, 29 June 2023. The lab work showed elevated monocytes. The reporter wanted to knowcan Shingrix cause elevated monocyte levels. The reporter was consented to follow up. This case has been linked with case US2023090631 reported by same reporter.; Sender's Comments:  US-GSK-US2023090631:Same Reporter
Patient received two full courses of Pfizer vaccine (1/7/21, 1/28/21) at the Fairgfounds site and the Moderna vaccine (1/5/21, 2/3/21) at clinic.
Patient received Pfizer for their initial series in January 2021.  Patient recently received a Moderna booster.  Patient subsequently developed a maculopapular rash on neck ~ 24 hours after receiving Moderna.  Symptoms resolved over several days with no intervention.
Patient complained of injection site pain & soreness. Pt had flu like symptoms (bodyache, nauseous, light-headed) the same night & was very lethargic 24 hrs following the shot.
Administration of vaccines after a below temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect product storage in a patient who received HAV (Havrix) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B) for prophylaxis, hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Reduced antigen) (Boostrix) for prophylaxis, dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis and Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Havrix, Havrix Pre-Filled Syringe Device, Engerix B, Engerix B Pre-Filled Syringe Device, Boostrix, Boostrix Pre-Filled Syringe Device and Shingrix. On an unknown date, unknown after receiving Havrix, Havrix Pre-Filled Syringe Device, Engerix B, Engerix B Pre-Filled Syringe Device, Boostrix, Boostrix Pre-Filled Syringe Device and Shingrix, the patient experienced incorrect product storage. On an unknown date, the outcome of the incorrect product storage was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 31-MAY-2022 Reporter's comment: The vaccine coordinator reported a below temperature excursion for Havrix, Engerix B, Shingrix, Boostrix at 30.21 degree F for 30 hours. The health care professional stated this excursion occurred on December 2021 and there might have been some patients that received those vaccines. The HCP was not able to provide any details from patients and or vaccination details. The reporter consented to follow up. Additional Supportive Information: The patients received vaccine after temperature excursion which led to incorrect storage of drug.
12/23 I developed difficulty breathing associated by a lot of yellow/greenish mucus more so in the mornings. Malayized and very tired resulting in me sleeping a lot. I just have this blah feeling. Terrible coughing resulting in extreme pain in the thoracic area mainly on the left side. I went to the ER but they took too long so I left so I went home and self administer with prednisone and additional breathing treatments and checked my pulse ox until it finally reached back to 96 because it had fallen to 84 during my SOB experience. And to date I am still experiencing these symptoms.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No medical history provided. The reporter stated that improperly stored GARDASIL may have been administered. No concomitant medications were provided. No adverse event was reported. Additional information is not expected.
Nausea; Stomach pain; This is a spontaneous report from a contactable nurse (patient's mother). A patient of unspecified age and gender received meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient's mother reported that meningococcal group b rlp2086 was administered, the patient had stomach pain and nausea on an unspecified date. The patient's mother was asking if stomach pain has been reported as an adverse effect of meningococcal group b rlp2086. Outcome of the events was unknown.
Pt received shot, stayed 10 minutes, felt well and went home. After getting home her arm was red and swollen from shoulder site down to elbow. Could not lift arm due to significant pain and felt throbbing in her arm with heartbeats. Patient treated herself with ibuprofen and ice since she could not contact her doctor over the holiday. As of 1/6/17 her arm is only slight red, swollen and sore.
Information has been received from a registered nurse concerning a 16 month female with no drug allergies and a history of respiratory syncytial virus infection who on 22-MAY-2008 was vaccinated SC with her first 0.5 ml dose of MMR II (lot# 658582/0043X). There was no concomitant medication. On that same day 15 minutes after administration, the patient experienced wheezing, hives and rhinorrhea. The patient sought medical attention at the office. No labs or diagnostic studies were performed. The patient was given epinephrine, BENADRYL and PRELONE. The symptoms were reduced with treatment and the reactions cleared and the patient recovered by the next day. There was no product quality complaint. The registered nurse considered wheezing, hives and rhinorrhea to be other important medical events. Additional information has been requested.
fever began on 24JUL96 PM rose to 104.9;also began vomiting;ER was called by mom & was told to give APAP & tepid bath;